Oramed Pharmaceuticals
ORMP
#8954
Rank
โ‚น15.11 B
Marketcap
โ‚น373.61
Share price
-1.26%
Change (1 day)
92.04%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2025 (TTM): โ‚น74.01

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น77.00. In 2024 the company made an earnings per share (EPS) of -โ‚น45.63 a decrease over its 2023 EPS that were of โ‚น13.31.

EPS history for Oramed Pharmaceuticals from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น74.01-262.18%
2024-โ‚น45.63-442.86%
2023โ‚น13.31-114.89%
2022-โ‚น89.3620.51%
2021-โ‚น74.1539.29%
2020-โ‚น53.24-31.71%
2019-โ‚น77.95-4.65%
2018-โ‚น81.768.86%
2017-โ‚น75.10-9.2%
2016-โ‚น82.7129.85%
2015-โ‚น63.698.06%
2014-โ‚น58.945.08%
2013-โ‚น56.093.51%
2012-โ‚น54.19137.5%
2011-โ‚น22.82-60%
2010-โ‚น57.04-0%
2009-โ‚น57.04-16.67%
2008-โ‚น68.45-25%
2007-โ‚น91.26700%
2006-โ‚น11.41303.56%
2005-โ‚น2.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
โ‚น337.56 338.37%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
โ‚น196.33 154.96%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚น555.19-820.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚น18.06-123.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-โ‚น28.52-137.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel